Chris Bower

758 total citations
20 papers, 105 citations indexed

About

Chris Bower is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Chris Bower has authored 20 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 10 papers in Applied Microbiology and Biotechnology and 9 papers in Epidemiology. Recurrent topics in Chris Bower's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotic Use and Resistance (10 papers) and Urinary Tract Infections Management (5 papers). Chris Bower is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotic Use and Resistance (10 papers) and Urinary Tract Infections Management (5 papers). Chris Bower collaborates with scholars based in United States, United Kingdom and Australia. Chris Bower's co-authors include Neil V. Whittock, Jesse T. Jacob, Sarah W. Satola, Ivan Bristow, Jessica Howard‐Anderson, Gillian Smith, Joseph D. Lutgring, David S. Weiss, Max W. Adelman and Dan I. Andersson and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Infection Control and Hospital Epidemiology.

In The Last Decade

Chris Bower

18 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Bower United States	6	61	23	21	19	19	20	105
John J. Manaloor United States	8	12 0.2×	11 0.5×	7 0.3×	75 3.9×	32 1.7×	18	165
Salman Motlekar India	8	29 0.5×	6 0.3×	24 1.1×	24 1.3×	24 1.3×	13	261
Tiffany Sin Yu Chan Canada	5	12 0.2×	3 0.1×	24 1.1×	46 2.4×	37 1.9×	10	156
Mohammed Elshaer Egypt	4	9 0.1×	6 0.3×	6 0.3×	18 0.9×	21 1.1×	16	58
Ulrike Laabs Germany	7	38 0.6×	3 0.1×	10 0.5×	82 4.3×	9 0.5×	7	347
Nicholas Gleadall United Kingdom	6	20 0.3×		7 0.3×	46 2.4×	12 0.6×	12	128
Nabil Gastli France	6	13 0.2×	8 0.3×	8 0.4×	3 0.2×	12 0.6×	9	78
Le Thi Dung Vietnam	5	16 0.3×	7 0.3×	1 0.0×	9 0.5×	18 0.9×	6	99
Tim Avis United Kingdom	5	16 0.3×	9 0.4×	3 0.1×	28 1.5×	5 0.3×	8	55
Amanda N. Seddon United States	4	13 0.2×	3 0.1×	7 0.3×	13 0.7×	15 0.8×	10	54

Countries citing papers authored by Chris Bower

Since Specialization

Citations

This map shows the geographic impact of Chris Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Bower more than expected).

Fields of papers citing papers by Chris Bower

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Bower. The network helps show where Chris Bower may publish in the future.

Co-authorship network of co-authors of Chris Bower

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Bower. A scholar is included among the top collaborators of Chris Bower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Bower. Chris Bower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Babiker, Ahmed, Chris Bower, Joseph D. Lutgring, et al.. (2022). Clinical and Genomic Epidemiology of mcr-9 -Carrying Carbapenem-Resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012 to 2017. Microbiology Spectrum. 10(4). e0252221–e0252221. 7 indexed citations

Howard‐Anderson, Jessica, Chris Bower, Gillian Smith, et al.. (2021). Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study. Journal of Antimicrobial Chemotherapy. 77(3). 793–798. 22 indexed citations

Howard‐Anderson, Jessica, Chris Bower, Gillian Smith, Sarah W. Satola, & Jesse T. Jacob. (2021). Mortality in patients with carbapenem-resistantPseudomonas aeruginosawith and without susceptibility to traditional antipseudomonal β-lactams. JAC-Antimicrobial Resistance. 3(4). dlab187–dlab187. 4 indexed citations

Howard‐Anderson, Jessica, Michelle Earley, Toshimitsu Hamasaki, et al.. (2021). 1219. Unfavorable Clinical Outcomes with Polymyxins Compared to Ceftolozane/Tazobactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa. Open Forum Infectious Diseases. 8(Supplement_1). S699–S700. 2 indexed citations

Adelman, Max W., Chris Bower, Julian E. Grass, et al.. (2021). Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort Study. Open Forum Infectious Diseases. 9(1). ofab643–ofab643. 11 indexed citations

Howard‐Anderson, Jessica, Chris Bower, Gillian Smith, et al.. (2020). Carbapenem-resistant Enterobacterales bacteriuria and subsequent bacteremia: A population-based study. Infection Control and Hospital Epidemiology. 42(8). 962–967. 5 indexed citations

Smith, Gillian, Chris Bower, Scott K. Fridkin, & Jesse T. Jacob. (2020). 1425. Impact of Social Determinants on Racial Differences in Carbapenem-Resistant Enterobacteriaceae Incidence, Atlanta, 2012-2018. Open Forum Infectious Diseases. 7(Supplement_1). S718–S719.

Reses, Hannah E., Kelly M Hatfield, Jesse T. Jacob, et al.. (2020). Characteristics Associated with Death in Patients with Carbapenem-Resistant Acinetobacter baumannii, United States, 2012–2017. Infection Control and Hospital Epidemiology. 41(S1). s59–s60. 1 indexed citations

Bower, Chris, Max W. Adelman, Jessica Howard‐Anderson, et al.. (2020). Carbapenem-Resistant Enterobacteriaceae Resistant Only to Ertapenem: An Epidemiologically Distinct Cohort, Atlanta, 2016–2018. Infection Control and Hospital Epidemiology. 41(S1). s463–s464. 1 indexed citations

10.

Bulens, Sandra N., Sophia V. Kazakova, Hannah E. Reses, et al.. (2020). Carbapenem-Resistant Acinetobacter baumannii Incidence Trends Identified Through the Emerging Infections Program, 2012–2018. Infection Control and Hospital Epidemiology. 41(S1). s462–s463.

11.

Campbell, Davina, Hannah E. Reses, Chris Bower, et al.. (2020). Epidemiologic Characteristics of ESBL-Producing ST131 E. coli Identified Through the Emerging Infections Program, 2017. Infection Control and Hospital Epidemiology. 41(S1). s214–s215. 1 indexed citations

12.

Howard‐Anderson, Jessica, Chris Bower, Gillian Smith, et al.. (2019). 506. Urinary Catheters Are Associated with Progression from Bacteriuria to Invasive Infections in Patients with Carbapenem-Resistant Enterobacteriaceae, Metropolitan Atlanta, 2011–2017. Open Forum Infectious Diseases. 6(Supplement_2). S245–S246. 1 indexed citations

13.

Bower, Chris, Hannah Wolford, Rachel B. Slayton, et al.. (2019). Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network Analysis. Clinical Infectious Diseases. 70(1). 75–81. 7 indexed citations

14.

Bulens, Sandra N., Hannah E. Reses, Maria Karlsson, et al.. (2018). 1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016. Open Forum Infectious Diseases. 5(suppl_1). S61–S62. 1 indexed citations

15.

Bower, Chris, et al.. (2017). Comparison of 30- and 90-Day Mortality Rates in Patients with Cultures Positive for Carbapenem-resistant Enterobacteriaceae and Acinetobacter in Atlanta, 2011–2015. Open Forum Infectious Diseases. 4(suppl_1). S44–S44. 3 indexed citations

16.

Bristow, Ivan & Chris Bower. (2016). Melanoma of the Foot. Clinics in Podiatric Medicine and Surgery. 33(3). 409–422. 9 indexed citations

17.

Bower, Chris, et al.. (2016). Recurrence of Positive Cultures for Carbapenem-Resistant Enterobacteriaceae in Atlanta. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

18.

Walters, Maroya Spalding, Sandra N. Bulens, Emily Hancock, et al.. (2016). Surveillance for Carbapenem-Resistant Pseudomonas aeruginosa at Five United States Sites—2015. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

19.

Watts, Andrew, et al.. (2013). A report of two patients with a history of pyoderma gangrenosum where total knee arthroplasty was performed under prophylactic immunosuppression. 5(1). 85–89. 1 indexed citations

20.

Whittock, Neil V. & Chris Bower. (2003). Targetting of desmoglein 1 in inherited and acquired skin diseases. Clinical and Experimental Dermatology. 28(4). 410–415. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact